Schwalb, Jason M.
Movement Disorder & Comprehensive Epilepsy Centers, Henry Ford Medical Group, West Bloomfield, Michigan, USA.
4 papers on CoChatORCID 0000-0002-8714-161X
Most cited papers
- Verified
Deep Brain Stimulation for Treatment-Resistant Depression
Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., Schwalb, J. M., & Kennedy, S. H. (2005) · Neuron
Deep Brain Stimulation and Movement DisordersTreatment of Major Depression
Cited by 4,059
- Verified
AAV2-GAD gene therapy for advanced Parkinson’s disease: a double-blind, sham-surgery controlled, randomised trial
LeWitt, P. A., Rezai, A. R., Leehey, M. A., Ojemann, S. G., Flaherty, A. W., Eskandar, E. N., Kostyk, S. K., Thomas, K., Sarkar, A., Siddiqui, M. S., et al. (2011) · The Lancet Neurology
Deep Brain Stimulation and Movement DisordersParkinson's Disease Mechanisms and Treatments
Cited by 681
- Verified · note
Practice guideline: Idiopathic normal pressure hydrocephalus: Response to shunting and predictors of response: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
Halperin, J. J., Kurlan, R., Schwalb, J. M., Cusimano, M. D., Gronseth, G., & Gloss, D. (2015) · Neurology
Cerebrospinal fluid and hydrocephalusNeurosurgical Procedures and Complications
Cited by 264
- Verified
Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson’s disease
Niethammer, M., Tang, C. C., LeWitt, P. A., Rezai, A. R., Leehey, M. A., Ojemann, S. G., Flaherty, A. W., Eskandar, E. N., Kostyk, S. K., Sarkar, A., et al. (2017) · JCI Insight
Deep Brain Stimulation and Movement DisordersParkinson's Disease Mechanisms and Treatments
Cited by 124
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free